| Page 36 | Cafepharma

You are here

Primary tabs

Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer

Post date: October 22, 2018 - 5:29pm

BeiGene Presents Data on it PARP Inhibitor in Combination With Temozolomide in Solid Tumors

Post date: October 22, 2018 - 10:01am

New Study Suggests Tumor Treating Fields Can Increase Progression-Free Survival in Pancreatic Cancer

Post date: October 22, 2018 - 9:47am

Rebiotix to Report on Development of its Microbiome Health Index

Post date: October 22, 2018 - 9:31am

TP Therapeutics Secures $80 Million Mezzanine Financing

Post date: October 19, 2018 - 9:29am

Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis

Post date: October 19, 2018 - 9:13am

Takeda's Alunbrig Showed Superior Intracranial Results Compared to Xalkori in Ph III Trial in Non-Small Cell Lung Cancer

Post date: October 19, 2018 - 9:05am

Symberix Announces Non-Dilutive Funding Support for Lead Programs

Post date: October 18, 2018 - 12:33am

LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity

Post date: October 17, 2018 - 11:38pm

Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs

Post date: October 17, 2018 - 10:23am

Pages